Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS: INTI · Delayed Price · USD
0.0700
0.00 (0.00%)
Mar 28, 2024, 9:37 AM EDT - Market open
Inhibitor Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Capitalization | 12 | 36 | 56 | 13 | 21 | 22 | 92 | 113 | 30 | 12 | 1 | Upgrade
|
Market Cap Growth | - | -35.77% | 333.55% | -37.25% | -6.51% | -75.89% | -18.29% | 272.40% | 152.30% | 714.72% | -28.13% | Upgrade
|
Enterprise Value | 3 | 25 | 57 | 13 | 20 | 21 | 92 | 106 | 30 | 12 | 2 | Upgrade
|
PE Ratio | 1.20 | 2.99 | -180.04 | -12.32 | -7.63 | -4.88 | -18.04 | -16.09 | -7.66 | -3.02 | -0.80 | Upgrade
|
PS Ratio | - | - | - | - | - | - | - | - | - | -452.46 | - | Upgrade
|
PB Ratio | 1.87 | 4.37 | -15.59 | -3.87 | -8.20 | 685.88 | 552.48 | 16.02 | 71.32 | 193.07 | -1.92 | Upgrade
|
P/FCF Ratio | 1.22 | 3.09 | -256.03 | -15.77 | -7.67 | -5.98 | -31.59 | -29.96 | -13.36 | -9.19 | -1.20 | Upgrade
|
P/OCF Ratio | 1.22 | 3.09 | -256.03 | -15.77 | -7.67 | -5.98 | -31.59 | -29.96 | -13.36 | -9.19 | -1.20 | Upgrade
|
EV/Sales Ratio | - | - | - | - | - | - | - | - | - | -438.67 | - | Upgrade
|
EV/EBITDA Ratio | 0.11 | -37.56 | -174.06 | -12.31 | -7.26 | -4.62 | -17.91 | -15.06 | -7.50 | -2.95 | -0.82 | Upgrade
|
EV/FCF Ratio | 0.25 | 2.10 | -256.94 | -15.80 | -7.37 | -5.68 | -31.47 | -28.13 | -13.09 | -8.91 | -1.26 | Upgrade
|
Debt / Equity Ratio | 0 | 0.05 | -0.06 | -0.03 | 1.19 | -12.37 | 0 | 0 | 0 | 0 | -0.09 | Upgrade
|
Debt / EBITDA Ratio | - | -0.62 | -0.71 | -0.09 | - | - | - | - | - | - | -0.04 | Upgrade
|
Debt / FCF Ratio | - | 0.04 | -1.05 | -0.12 | - | - | - | - | - | - | -0.06 | Upgrade
|
Quick Ratio | 60.97 | 17.61 | 0.05 | 0.18 | 1.86 | 1.58 | 0.57 | 22.35 | 1.30 | 0.91 | 0.00 | Upgrade
|
Current Ratio | 61.41 | 17.64 | 0.09 | 0.25 | 1.96 | 1.64 | 1.09 | 23.36 | 1.38 | 1.15 | 0.01 | Upgrade
|
Asset Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.06 | 0 | Upgrade
|
Interest Coverage | 0 | -28.32 | -21.93 | 0 | 0 | 0 | 0 | 0 | 0 | -105.06 | -1039.94 | Upgrade
|
Return on Equity (ROE) | 363.25% | 145.92% | 8.66% | 31.45% | 107.41% | -14065.19% | -3062.60% | -99.58% | -931.55% | -6403.61% | 239.61% | Upgrade
|
Return on Assets (ROA) | 243.91% | 101.09% | -533.26% | -802.12% | -302.10% | -369.04% | -664.17% | -95.40% | -445.85% | -858.64% | -17960.81% | Upgrade
|
Return on Capital (ROIC) | -87.93% | -7.52% | 9.60% | 32.45% | 108.56% | -14108.55% | -3073.33% | -99.89% | -931.55% | -6343.24% | 286.75% | Upgrade
|
Earnings Yield | 194.61% | 33.39% | -0.56% | -8.12% | -13.11% | -20.51% | -5.54% | -6.22% | -13.06% | -33.17% | -124.74% | Upgrade
|
FCF Yield | 82.18% | 32.39% | -0.39% | -6.34% | -13.04% | -16.71% | -3.17% | -3.34% | -7.49% | -10.88% | -83.18% | Upgrade
|
Dividend Yield | 0.25% | 0.52% | 0.18% | 0.77% | 0.48% | 0.25% | 0.00% | 0.00% | 0.00% | 8.51% | 0.00% | Upgrade
|
Payout Ratio | 0.36% | 1.56% | -32.16% | -9.54% | -3.65% | -1.24% | 0.00% | 0.00% | 0.00% | -25.66% | 0.00% | Upgrade
|
Buyback Yield / Dilution | 54.36% | 2.25% | -1.16% | -0.40% | -0.17% | -0.87% | -26.97% | -24.13% | -142.60% | -434.46% | -31.47% | Upgrade
|
Total Shareholder Return | 54.36% | 2.77% | -0.98% | 0.37% | 0.31% | -0.62% | -26.97% | -24.13% | -142.60% | -425.95% | -31.47% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.